Literature DB >> 2393290

Influence of plasma exchange pheresis on plasma elimination of ceftriaxone.

J S Bakken1, S J Cavalieri, D Gangeness.   

Abstract

The plasma elimination rates of serial 2-g intravenous injections of ceftriaxone were studied in a patient who also was treated with therapeutic plasma exchange pheresis. Plasmapheresis had negligible influence on the total clearance of ceftriaxone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393290      PMCID: PMC171801          DOI: 10.1128/AAC.34.6.1276

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis.

Authors:  G M McKhann; J W Griffin; D R Cornblath; E D Mellits; R S Fisher; S A Quaskey
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

2.  Ceftriaxone: renal and biliary excretion and effect on the colon microflora.

Authors:  A Arvidsson; G Alván; B Angelin; O Borgå; C E Nord
Journal:  J Antimicrob Chemother       Date:  1982-09       Impact factor: 5.790

3.  Kinetics of ceftazidime during plasmapheresis.

Authors:  F Bozkurt; P Schollmeyer; E Keller
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

5.  Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

Authors:  K Stoeckel; P J McNamara; R Brandt; H Plozza-Nottebrock; W H Ziegler
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

  5 in total
  4 in total

1.  Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.

Authors:  Charles Burdet; Nathalie Grall; Morgane Linard; Antoine Bridier-Nahmias; Michèle Benhayoun; Khadija Bourabha; Mélanie Magnan; Olivier Clermont; Camille d'Humières; Olivier Tenaillon; Erick Denamur; Laurent Massias; Sarah Tubiana; Loubna Alavoine; Antoine Andremont; France Mentré; Xavier Duval
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Influence of therapeutic plasmapheresis on elimination of ceftiaxone.

Authors:  J S Bakken; S J Cavalieri; D Gangeness; T Kubat; J R Pollack
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

3.  Models of antimicrobial pressure on intestinal bacteria of the treated host populations.

Authors:  V V Volkova; C L Cazer; Y T Gröhn
Journal:  Epidemiol Infect       Date:  2017-05-02       Impact factor: 4.434

4.  Mathematical model of plasmid-mediated resistance to ceftiofur in commensal enteric Escherichia coli of cattle.

Authors:  Victoriya V Volkova; Cristina Lanzas; Zhao Lu; Yrjö Tapio Gröhn
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.